why stop glp 1 before surgery do you need to Perioperative management of patients taking glucagon Glucagon-Like Peptide 1 Receptor Agonists

Burckbuchler V, Mekhloufi G, Giteau AP, Grossiord JL, Huille S, Agnely F

Because of the potential risks of high-dose magnesium supplementation, especially in those with impaired kidney function, supplementation with magnesium should be conducted under medical supervision

For people with obesity-related conditions like type 2 diabetes, cardiovascular disease, or sleep apnea, that delay carries medical risk

Another randomized controlled clinical trial specifically focusing on their weight loss effects demonstrated that, in adults with overweight or obesity without diabetes, once-weekly subcutaneous injection of semaglutide resulted in significantly greater weight loss at 68 weeks compared with once-daily subcutaneous injection of liraglutide, and the incidence of gastrointestinal adverse reactions was similar between the two groups [Reference Rubino, Greenway, Khalid, ONeil, Rosenstock and Srrig47]